Results 251 to 260 of about 15,414 (282)
Some of the next articles are maybe not open access.
Acta Endocrinologica, 1978
ABSTRACT Increases in serum triglycerides, cholesterol and pre-β- and β-lipoproteins have been considered as significant pathogenic factors regarding the possible thrombotic side-effect of treatment with oral contraceptives of the combined type containing synthetic oestrogen.
E. Bostofte +4 more
openaire +1 more source
ABSTRACT Increases in serum triglycerides, cholesterol and pre-β- and β-lipoproteins have been considered as significant pathogenic factors regarding the possible thrombotic side-effect of treatment with oral contraceptives of the combined type containing synthetic oestrogen.
E. Bostofte +4 more
openaire +1 more source
Archiv f�r Gyn�kologie, 1973
The amounts of luteinizing hormone (LH) and follicle stimulating hormone (FSH) released in response to the intravenous administration of 12.5, 25, and 100μg of LH-Releasing Hormone (LH-RH) were found to be severely impeded in 4 out of 5 women who had been taking oral contraceptives for periods ranging from 12 to 36 months.
Robyn, Claude +4 more
openaire +2 more sources
The amounts of luteinizing hormone (LH) and follicle stimulating hormone (FSH) released in response to the intravenous administration of 12.5, 25, and 100μg of LH-Releasing Hormone (LH-RH) were found to be severely impeded in 4 out of 5 women who had been taking oral contraceptives for periods ranging from 12 to 36 months.
Robyn, Claude +4 more
openaire +2 more sources
International Journal of Oncology, 2005
Overexpression of the lipogenic enzyme fatty acid synthase (FAS) is a common molecular feature in subsets of sex-steroid-related tumors including breast carcinomas that is associated with poor prognosis. In this study, we explored whether breast-cancer associated FAS (oncogenic antigen-519) is regulated by the progestin component in oral contraceptives.
Javier A, Menendez +3 more
openaire +2 more sources
Overexpression of the lipogenic enzyme fatty acid synthase (FAS) is a common molecular feature in subsets of sex-steroid-related tumors including breast carcinomas that is associated with poor prognosis. In this study, we explored whether breast-cancer associated FAS (oncogenic antigen-519) is regulated by the progestin component in oral contraceptives.
Javier A, Menendez +3 more
openaire +2 more sources
[Synthetic estrogen as a endocrine disruptor--diethylstilbestrol and oral contraceptives].
Nihon rinsho. Japanese journal of clinical medicine, 2001Recently, considerable attention has been focused on certain environmental contaminants, endocrine disruptors, of industrial origin that may mimic the action of estrogen. Oral contraceptives containing ethynylestradiol, a synthetic estrogen, have been suspected to have adverse environmental effects since prenatal exposure to diethylstilbestrol, another
Y, Takai, O, Tsutsumi
openaire +1 more source
Nihon rinsho. Japanese journal of clinical medicine, 1999
Most users of synthetic-steroid hormones for postmenopausal hormone replacement or contraception, are healthy with a low background incidence of major diseases. Since they take these medicines for a long time, serious or frequent adverse effects should not be occurred.
H, Sugawara, M, Kawakami
openaire +1 more source
Most users of synthetic-steroid hormones for postmenopausal hormone replacement or contraception, are healthy with a low background incidence of major diseases. Since they take these medicines for a long time, serious or frequent adverse effects should not be occurred.
H, Sugawara, M, Kawakami
openaire +1 more source
Atherosclerosis, 1986
Recent epidemiological data indicate that the risk of thromboembolic disease associated with oral contraception (OC) may persist after discontinuation of the drug. It was demonstrated on the other hand that antibodies to sex steroid hormones which develop in OC users, were significantly correlated with the incidence of thrombosis. It is well known that
V, Beaumont +3 more
openaire +1 more source
Recent epidemiological data indicate that the risk of thromboembolic disease associated with oral contraception (OC) may persist after discontinuation of the drug. It was demonstrated on the other hand that antibodies to sex steroid hormones which develop in OC users, were significantly correlated with the incidence of thrombosis. It is well known that
V, Beaumont +3 more
openaire +1 more source
Engineering living therapeutics with synthetic biology
Nature Reviews Drug Discovery, 2021Andres Cubillos-Ruiz +2 more
exaly
Present and future of synthetic cell development
Nature Reviews Molecular Cell Biology, 2023Marileen Dogterom +2 more
exaly